2020 “Yinhua Fund Cup” Sina bank financial planner competition, hot registration. From now on to September 7, you will receive free gift packages worth more than 700 yuan from Guan Qingyou, Luo Yuanshang and Chen Kaifeng. < p > < p > Andersen stable double interest held mixed fund manager manor for three months, and Anxin stable double interest held mixed proposed fund manager Zhang Ming for three months. Sharing theme: new opportunities for new shares, good season red < / P > < p > whether it’s taking advantage of ant group’s listing, trading 10 times in 11 days, or formally releasing Huatai Insurance some time ago, it has made a lot of money Or the history of its growth and development, there are too many stories to elaborate on. < p > < p > the stocks that opened at 3.11 yuan per share on the same day rose to about 10 yuan per share in less than a month, and the market value rose to 80 billion yuan. Although during this period, the company repeatedly issued Clarification Announcement, but investors’ enthusiasm did not decrease, and the price naturally rose. < / P > < p > as a traditional chemical enterprise with PVC as its main products, although its business income has been on the rise in recent years, the market value of the company has been declining due to the development cycle of the chemical industry, environmental protection policies and other factors. < p > < p > on July 20, the official of ant group announced that it planned to seek synchronous listing on the A-share sci tech innovation board and the main board of the Hong Kong stock exchange. As one of the most powerful companies in China, the subtle action of an ant is enough to excite the whole capital forest. For a time, stocks related to ant concept are bullish. As the financial company with ant group as its largest shareholder, Tianhong fund is certainly favored by the public. In the process of finding the structure of the Celestica fund, the financial company of the wild horse (WeChat official account: ymcj8686) found that in the group of investors of the Celestica fund, the name of the group is impressively listed, and is also its third largest shareholder. < p > < p > on June 23, Junzheng group announced that Huatai Insurance Group had received the approval of cbcirc to transfer its 15.3% equity of Huatai to anda Tianping reinsurance at RMB 7.387 billion. Once the equity transfer is completed, the shareholding ratio of Junzheng group in Huatai Insurance will be reduced from 22.36% to 7.05%, while that of Anda will rise from 30.9% to 46.2%. < p > < p > in 2014, Junzheng Group acquired 15.2951% equity of Huatai Insurance at a price of 4.504 billion through public transfer. A year later, Junzheng group again injected 2.019.6 billion yuan, which included 6.9747% equity of Huatai. By the end of 2018, “Junzheng sold for the third time and transferred 0.087% equity of Huatai Insurance from Sinochem supply and marketing at a price of 18.725 million yuan. Since then, junzhengxi has held 22.3568% of Huatai’s equity. According to this calculation, some of the shares sold by “junzhengxi” have helped it to earn a profit of about 2.926 billion, with a yield of nearly 44.73% within six years. And all the rich returns are naturally inseparable from the development path of “Junzheng system” with extensive investment and cross-border love. < p > < p > in addition to owning Junzheng shares engaged in energy and chemical industry, Du Jiangtao’s “Junzheng system” has stepped on the capital market, and the banner displayed before the public is Bohui innovation (300318. SZ) with biotechnology as its core business. Of course, in addition to these two enterprises, Tianhong Fund Management Co., Ltd., Guodu Securities Co., Ltd., Wuhai Zhengwei Mining Co., Ltd., Chuanglian energy and Erdos Hongfeng coal mine have close ties with him. At present, “Junzheng system” has set foot in many fields, such as finance, chemical industry, insurance, Internet, biological medicine and so on. As for the current development track of “Junzheng system”, enterprise observer Yang Jianyuan commented: “although Junzheng system was born in Inner Mongolia and started with coal chemical industry, from the perspective of the profit channels of enterprises in recent years, the investment return accounts for a large proportion in the profit sources. And fortunately, Junzheng’s investment vision is still very accurate and original, winning more than losing less. After the recent 10 consecutive rising events, Junzheng system and the concept of new crown vaccine had a spark, which must lead to a burst of stock price rise. ” Indeed, the net investment income of Junzheng group in recent three years has reached 546 million yuan, 568 million yuan and 640 million yuan respectively. Among them, the typical representative should also be Tianhong fund. In May 2008, Shanxi Zhangze Electric Power Co., Ltd. transferred its 26% Tianhong fund equity to Wuhai Junzheng Energy Chemical Co., Ltd. At that time, the Celestica fund was not authoritative. Nobody could have imagined that with the rise of the “Ali Department” in the payment field, the emergence of Alipay made the product of Tianhong fund expand rapidly. After that, the ant gold service was also a gold-plated layer. < p > < p > < p > “Junzheng system” seized the opportunity without hesitation and signed the subscription agreement for capital increase. Later, Alibaba announced that it acquired 51% equity with 1.18 billion yuan of capital, and became the first one; Junjie increased capital by about 6900 yuan, firmly holding 15.6% of tianhongjiang mountain. Of course, in addition to Tianhong, Huatai Insurance and Guodu securities mentioned above are all his masterpieces. However, behind the large-scale investment, there are also hidden worries. According to the announcement issued by Junzheng group on June 11, Du Jiangtao’s pledge of 81 million shares was released from the pledge. However, Du Jiangtao and his person acting in concert, Junzheng technology, have not yet released the pledge. There are 1.446 billion shares in the pledged state, accounting for nearly 17% of the total share capital of the company. In July, Du Jiangtao pledged his massive shares of 13.35% and 13.03% twice. During the peak period, the cumulative amount of shares pledged by Du Jiangtao has reached nearly 95% of his personal shares. < / P > < p > the funds pledged must be basically used to meet the investment demand. According to the financial statements released by enterprises, the net cash flow of investment activities in 2017-2019 will reach -3.831 billion, – 2.104 billion and – 3.018 billion respectively. At the age of 18, he entered Beijing University of technology with the second place in Wuhai City. It is worth mentioning that Hao Hong, the city’s number one scholar, later became his wife. After bidding farewell to the ivory tower, Du Jiangtao established Junzheng Investment Management Consulting Co., Ltd. in Beijing. Its main business is securities investment consulting, which is the founding company of “Junzheng system”. With his accurate judgment of the market and the current situation, he made a lot of money by buying three barrels of oil stocks. After that, he returned to his hometown and successively invested in ferrosilicon projects and acquired Inner Mongolia Yellow River Chemical Group. At the same time, he gave full play to the advantages of rich ore resources in Inner Mongolia, and made a breakthrough in the fields of thermal power generation, ore, PVC caustic soda, etc. in just a few years, Junzheng group’s assets expanded to 3 billion yuan. < / P > < p > on April 25, 2018, a sudden case brought a big shadow to Du Jiangtao’s brilliant career and brilliant facilities. In March of the following year, Du was ordered to resign from his official status, according to zhongxin.com. It is worth noting that Du Jiangtao no longer serves as the corporate facade of the enterprises under the “Junzheng system”, but he still “works hard” for the company’s investment matters. < p > < p > in February this year, Junzheng group had been inquired by the Shanghai Stock Exchange on the acquisition of Da’an pharmaceutical, a related party of Bohui innovation holdings. This blood products company, nearly 16 years after its establishment, is still facing the embarrassment of not obtaining the necessary qualifications. In the relevant reply announcement, Du Jiangtao promised: “if Da’an pharmaceutical does not obtain the production approval of jingc and PCC products in the next 12 months, I will purchase all the equity of Daan pharmaceutical held by Junzheng group according to the initial investment cost plus the interest of 6% of the previous year”. As for the final result, only time can give the answer. < / P > < p > < p > the development of “Junzheng system” is accompanied by a very enterprising spirit. However, we do not know whether the changeable market and the future development of the company can bear this spirit. Are you optimistic about the future development of Junzheng system? Welcome to leave a message in the comments area.